## Abstract Angiogenesis, the formation of new blood vessels, is controlled by a balance between positive and negative endothelial regulatory factors. Soluble vascular endothelial growth factor receptorβ1 (sVEGFR1), a naturally occurring soluble form of VEGFR1, is a negative counterpart of the vasc
Expression of Vascular Endothelial Growth Factor (VEGF) Family Members in Breast Cancer
β Scribed by Kurebayashi, Junichi ;Otsuki, Takemi ;Kunisue, Hironori ;Mikami, Yoshinori ;Tanaka, Katsuhiko ;Yamamoto, Shigeru ;Sonoo, Hiroshi
- Book ID
- 108581810
- Publisher
- Wiley (Blackwell Publishing)
- Year
- 1999
- Tongue
- English
- Weight
- 229 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0910-5050
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Vascular endothelial growth factor (VEGF) is a specific endothelial cell mitogen that stimulates angiogenesis and plays a crucial role in tumor growth. The aim of the present study was to evaluate the expression of VEGF and of its two high-affinity tyrosine kinase receptors (KDR and Flt-
Studies have shown that microvessel density influences breast-cancer prognosis. Since tumor angiogenesis is considered to be substantially affected by the excretion of vascular endothelial growth factor (VEGF) from tumor cells, we examined whether VEGF concentration is different in malignant and in